Cargando…

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis

INTRODUCTION: We systematically assessed benefits and harms of tocilizumab (TCZ), which is an antibody blocking IL-6 receptors, in hospitalized COVID-19 patients. METHODS: Five electronic databases and two preprint webpages were searched until March 4, 2021. Randomized controlled trials (RCTs) and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piscoya, Alejandro, Parra del Riego, Angela, Cerna-Viacava, Renato, Rocco, Jonathon, Roman, Yuani M., Escobedo, Angel A., Pasupuleti, Vinay, White, C. Michael, Hernandez, Adrian V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165853/ https://www.ncbi.nlm.nih.gov/pubmed/35657993 http://dx.doi.org/10.1371/journal.pone.0269368

Ejemplares similares

Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2021)

Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2020)

Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2022)

Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Efficacy of 5-Nitroimidazoles for the Treatment of Giardiasis: A Systematic Review of Randomized Controlled Trials
por: Pasupuleti, Vinay, et al.
Publicado: (2014)

Efficacy of early treatment with hydroxychloroquine in people with mild to moderate COVID-19: a systematic review and meta-analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)

Acute Endovascular Reperfusion Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Osanai, Toshiya, et al.
Publicado: (2015)

Renal Denervation for Uncontrolled and Resistant Hypertension: Systematic Review and Network Meta-Analysis of Randomized Trials
por: Silverwatch, Jonathan, et al.
Publicado: (2021)

An Internist’s Approach to a Case of Negative Pressure Pulmonary Edema: A Rare Cause of Noncardiogenic Pulmonary Edema
por: Cerna-Viacava, Renato, et al.
Publicado: (2023)

A Case of Malaria-Associated Hemophagocytic Lymphohistiocytosis
por: Almajed, Mohamed Ramzi, et al.
Publicado: (2022)

First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
por: Mastroianni, Fiore
Publicado: (2020)

Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
por: Arriola-Montenegro, Jose, et al.
Publicado: (2023)

Efficacy of Tunnel Technique (TUN) versus Coronally Advanced Flap (CAF) in the Management of Multiple Gingival Recession Defects: A Meta-Analysis
por: Mayta-Tovalino, Frank, et al.
Publicado: (2023)

Effects of Probiotics on Intermediate Cardiovascular Outcomes in Patients with Overweight or Obesity: A Systematic Review and Meta-Analysis
por: Mayta-Tovalino, Frank, et al.
Publicado: (2023)

Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
por: Miao, Benjamin, et al.
Publicado: (2020)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials
por: Hernandez, Adrian V., et al.
Publicado: (2023)

Compression wraps as adjuvant therapy in the management of acute systolic heart failure
por: Fadel, Raef Ali, et al.
Publicado: (2023)

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2021)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in COVID-19 patients
por: Zheng, Kai-Lian, et al.
Publicado: (2020)

Cortisone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Lack of efficacy: 10 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
por: Abidi, Emna, et al.
Publicado: (2022)

Tocilizumab as a possible cause of ischemic colitis()
por: Forneiro Pérez, Rocío, et al.
Publicado: (2021)

Deficient Reporting and Interpretation of Non-Inferiority Randomized Clinical Trials in HIV Patients: A Systematic Review
por: Hernandez, Adrian V., et al.
Publicado: (2013)

Use of Tocilizumab in patients with stable chronic liver disease and severe COVID-19 for prevention of decompensated cirrhosis, a prospective, open-label, randomized controlled trial.
por: Rosales Renteria, Luis Alejandro, et al.
Publicado: (2022)

Short-term outcomes of endoscopic submucosal dissection for the treatment of superficial gastric neoplasms in non-Asian countries: a systematic review and meta-analysis
por: Benites-Goñi, Harold, et al.
Publicado: (2023)

Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
por: Sarabia De Ardanaz, Luis, et al.
Publicado: (2021)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

1627 Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
por: Lloyd, Aaron, et al.
Publicado: (2014)

On language – first, do no harm
por: Schumann, Roman
Publicado: (2022)

Tocilizumab in the Management of COVID-19: A Preliminary Report
por: Li, Michael, et al.
Publicado: (2021)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tejc6vpnf06r78bbthf9f52qe